By Ben Adams
|Synexus CEO Christophe Berthoux|
The site management organization Synexus has strengthened its global reach with the acquisition of Research Across America, marking its arrival into the lucrative U.S. market.
The deal also boosts Reading, U.K.-based Synexus' expertise in areas such as dermatology and generics. Financial details of the deal weren't disclosed.
Dallas-headquartered Research Across America was founded in 1992 by TV personality Dr. Jeffrey Adelglass, and it currently works with a number of pharma companies and CROs.
Synexus, which was taken private in 2007 and claims to be the world's largest multi-national company dedicated to the recruitment and running of clinical trials at its own research centers, currently owns 25 research sites across 10 countries, but this deal gives the firm its first path into the U.S.
Christophe Berthoux, Synexus CEO, said: "Synexus already has a strong international footprint. This latest acquisition is important as it marks our entry into the U.S. market, giving us truly global capability. We spent a great deal of time considering an appropriate partner and selected Research Across America as it has a number of synergies with the Synexus model."
This latest deal builds on Synexus' buy-and-grow strategy that has seen it expand rapidly across Europe.
- read the statement